QH103E

· Chinese PLA General Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QH103E, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL [Phase 1, Phase 2]